En développement
Santé·02/06/2026Résumé IA
New Drug Spares Bladder Cancer Patients Life-Changing Surgery
An immunotherapy drug, durvalumab, combined with chemotherapy and radiotherapy, has shown promise in treating bladder cancer, potentially sparing patients radical surgery and preventing tumor recurrence. Results presented at a major cancer conference indicated an 85% success rate in a trial.
G
Guardian UK3 min de lecture